Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Credit agrmnt [a]
Quarterly results
Appointed director
CC transcript
Inv. presentation
Option Care Health, Inc. (BIOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/02/2017 8-K/A Quarterly results
Docs: "BioScrip Reports Third Quarter 2017 Financial Results - Net revenue of $198.7 million, including core product mix of 75.0%, compared to 65.8% in the prior year - Net revenue and adjusted EBITDA reduced $10.0 million and $3.0 million, respectively, due to sales disruption from Hurricane Irma, Hurricane Harvey, and completion of the UnitedHealthcare contract transition - Net loss from continuing operations of $12.4 million, compared to $11.1 million in the prior year - Adjusted EBITDA of $13.0 million, more than three times the prior year, driven by a 590 basis point improvement in gross profit margin and a $4.8 million reduction in operating expenses - Operating cash use of $0.3 million, reflecting $15.8 million of interest, including $8.9 million of bi-annual bond interest payments, and $1..."
08/08/2017 8-K/A Quarterly results
Docs: "BioScrip Reports Second Quarter 2017 Financial Results - Net revenue of $218.1 million, including core product mix of 73.1% compared to 60.3% in the prior year - Net loss from continuing operations of $28.7 million, compared to $8.3 million in the prior year, reflecting increased non-cash expenses and interest - Adjusted EBITDA of $10.0 million, nearly doubling from the first quarter of 2017 - Operating Cash Flow of $6.5 million, reflecting $23 million of operational and working capital improvements over the prior year - Liquidity of $50.5 million, including $40.5 million of cash, compared to $16.0 million at March 31, 2017 - Restructuring expenses of $3.9 million, primarily costs related to the ongoing optimization of the Company’ s workforce - The Company reaffirms EBITDA guidance and up..."
06/17/2016 8-K/A Other Events, Financial Statements and Exhibits
Docs: "The First Amendment, to the Asset Purchase Agreement, by and among HS Infusion Holdings, Inc., the direct and indirect subsidiaries of HS Infusion Holdings, Inc. set forth on the signature pages, the Company and HomeChoice Partners, Inc"
03/24/2015 8-K/A Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Addendum to the Warrant Agreement dated March 23, 2015, by and among Bioscrip, Inc., Coliseum Capital Partners, L.P., Coliseum Capital Partners II, L.P., and Blackwell Partners, LLC, Series A"
11/08/2013 8-K/A Form 8-K/A - Current report [Amend]
12/30/2010 8-K/A Form 8-K/A - Current report [Amend]
04/05/2005 8-K/A Form 8-K/A - Current report [Amend]
09/28/2004 8-K/A Form 8-K/A - Current report [Amend]
04/16/2002 8-K/A Form 8-K/A - Current report [Amend]
10/18/2000 8-K/A Form 8-K/A - Current report [Amend]
12/14/1998 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy